CME eLearning modules
Free accredited learning - Receive 1 European CME credit (ECMEC®) for successful completion.
This course is relevant for primary care physicians and all healthcare professionals who are involved in the care of patients with IPF.
16th March 2020
This course consists of an introduction, four sections and an assessment and closing survey.
- Introduction - introduction to the CME course - 5 minutes
- Section 1 - Burden and pathogenesis of IPE - 15 minutes
- Section 2 - Diagnosing IPF - 15 minutes
- Section 3 - Disease-modifying treatment - 15 minutes
- Section 4 - Non disease-modifying treatment - 15 minutes
- Section 5 - Assessment and closing survey - 5 minutes
Quick baseline questions will be asked at the start of each section to assess your background and understanding. You will not be assessed on your responses to these questions.
Evaluation questions will be asked at the end of the module. You must achieve a score of 70% or above to pass the course.
On completion of this course, participants will understand:
- The underlying burden that IPF places on patients and carers
- How to recognise symptoms and definitively diagnose IPF
- The importance of early diagnosis in order to access disease-modifying treatment
- The role of non disease-modifying treatment for patients with IPF
Professor Elisabeth Bendstrup. Senior consultant and associate professor at the Department of Respiratory Diseases and Allergy at Aarhus University Hospital, Denmark. She is head of the hospital’s ILD unit (the Danish Centre for Interstitial Lung Diseases and Sarcoidosis), which is a tertiary referral centre for ILD and sarcoidosis.
Professor Martin Kolb. Martin Kolb is Moran Campbell Professor in Respiratory Medicine at McMaster University and the Firestone Institute for Respiratory Health in Hamilton, ON, Canada. Professor Kolb’s major research area is focused on mechanisms of lung injury, repair and fibrosis, particularly in IPF and he is Chief Editor of the European Respiratory Journal.
Second module to be launched in late spring.
This content has been developed independently of the sponsors, Boehringer Ingelheim, who have had no editorial input into the content. Medthority received educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.